Dallas, Texas-based doctors report they have been able to drastically slash death rates among COVID-19 Coronavirus patients with telemedicine and home care.  Hospitalization was only needed in 1.9% of 922 treated patients.  This striking study was published in the December 30 issue of Reviews in Cardiovascular Medicine.

Doctors initially used an array of treatments that included an antibiotic and either zinc, hydroxychloroquine or ivermectin.  For more severe patients, clinic visits for intravenous magnesium, vitamin B1 (thiamine), plus other oral B vitamins and nebulized medication were employed and considered safe and feasible.

Only 35.6% of the 922-treated patients tested positive for COVID-19 by PCR test; another 591 test-negative patients were considered false negatives as they went on to develop more serious symptoms.  This suggests the PCR nasal swab test is largely inaccurate.  Only 1.9% of these patients needed to be hospitalized.

While the US has a COVID-19 mortality rate of 877 per million, India, a third-world country, has only 102 deaths per million, suggesting room for improvement in care.

First treat-at-home approach utilized telemedicine. 

A comparable study conducted at another hospital in Texas where the same medicines were used resulted in a 5.8% mortality rate.  Reduction in mortality rate to 0.3% was demonstrably superior to hospital care.

The trauma of hospitalization plus the potential risk for medication errors, antibiotic resistance and ventilator-induced lung disease, along with sunshine vitamin D deprivation, suggests hospitalization itself may be too traumatic and hazardous for many patients, especially the frail elderly.